Jun 12, 2026 06:00AM
May 21, 2026 06:00AM
Jul 10, 2025 06:00AM
Jun 12, 2025 06:00AM
May 27, 2025 06:00AM
May 14, 2025 04:05PM
Jun 14, 2024 06:00AM BeiGene to Present New Data from SEQUOIA Study Evaluating BRUKINSA® plus Venetoclax in High-Risk First-Line CLL/SLL at EHA2024
May 14, 2024 04:01PM
Oct 20, 2023 06:00AM
May 30, 2023 07:04AM
May 30, 2023 07:00AM
May 6, 2023 08:00AM
Jan 19, 2023 05:03PM
Jan 19, 2023 07:00AM BRUKINSA® (zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukemia (CLL) and Marginal Zone Lymphoma (MZL) in Great Britain by MHRA
Nov 22, 2022 08:30AM
Nov 17, 2022 07:00AM
Oct 14, 2022 06:30AM
Jun 10, 2022 07:00AM

66,737 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All